Same Indication

Midazolam vs Upadacitinib

Midazolam vs Upadacitinib: Overview

This comparison examines the pharmacological differences between Midazolam and Upadacitinib.

Mechanism of Action

Midazolam: Ultra-short-acting benzodiazepine GABA-A receptor positive allosteric modulator.

Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

Pharmacokinetics

Half-life: Midazolam — 1.5-2.5 hours; Upadacitinib — 9-14 hours.

Chemical Properties

Molecular Formula: Midazolam — C18H13ClFN3; Upadacitinib — C17H19F3N6O.

Molecular Weight: Midazolam — 325.7670 g/mol; Upadacitinib — 380.3700 g/mol.

Type: Midazolam — Small molecule; Upadacitinib — Small molecule.